AU4314196A - Solid composition with improved solubility and absorbability - Google Patents
Solid composition with improved solubility and absorbabilityInfo
- Publication number
- AU4314196A AU4314196A AU43141/96A AU4314196A AU4314196A AU 4314196 A AU4314196 A AU 4314196A AU 43141/96 A AU43141/96 A AU 43141/96A AU 4314196 A AU4314196 A AU 4314196A AU 4314196 A AU4314196 A AU 4314196A
- Authority
- AU
- Australia
- Prior art keywords
- absorbability
- solid composition
- improved solubility
- solubility
- improved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6-318580 | 1994-12-21 | ||
JP31858094 | 1994-12-21 | ||
PCT/JP1995/002611 WO1996019239A1 (en) | 1994-12-21 | 1995-12-20 | Solid composition with improved solubility and absorbability |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4314196A true AU4314196A (en) | 1996-07-10 |
Family
ID=18100727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43141/96A Abandoned AU4314196A (en) | 1994-12-21 | 1995-12-20 | Solid composition with improved solubility and absorbability |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4314196A (en) |
WO (1) | WO1996019239A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011105070A1 (en) | 2010-02-25 | 2011-09-01 | パナソニック株式会社 | Demand and supply control apparatus, demand and supply control method, and program |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2287971T3 (en) | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | SOLID PHARMACEUTICAL DISPERSIONS WITH INCREASED BIODISPONIBILITY. |
US6706283B1 (en) | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
ATE433318T1 (en) * | 1999-02-10 | 2009-06-15 | Pfizer Prod Inc | OSMOTIC SYSTEM FOR ADMINISTRATION OF ACTIVE INGREDIENTS CONTAINING SOLID AMORPHOUS DISPERSIONS |
EP1027886B1 (en) | 1999-02-10 | 2008-07-09 | Pfizer Products Inc. | Pharmaceutical solid dispersions |
YU43702A (en) | 1999-12-23 | 2004-11-25 | Pfizer Products Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
US20040058956A1 (en) * | 2000-12-11 | 2004-03-25 | Yohko Akiyama | Pharmaceutical composition having an improved water solubility |
KR20040025881A (en) * | 2000-12-11 | 2004-03-26 | 다케다 야쿠힌 고교 가부시키가이샤 | Medicinal compositions having improved absorbability |
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
ATE395044T1 (en) | 2002-02-01 | 2008-05-15 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS OF AMORPHIC DISPERSIONS OF ACTIVE INGREDIENTS AND LIPOPHILIC MICROPHASE-FORMING MATERIALS |
MY128945A (en) * | 2002-04-16 | 2007-03-30 | Kowa Co | Solid dispersion composition |
DE60334391D1 (en) | 2002-10-02 | 2010-11-11 | Meiji Seika Kaisha | ANTIBACTERIAL MEDICAL COMPOSITION WITH INCREASED ORAL ABSORPTION |
JP2007501218A (en) | 2003-08-04 | 2007-01-25 | ファイザー・プロダクツ・インク | Pharmaceutical composition of adsorbate of amorphous drug and lipophilic microphase-forming substance |
PT1671635E (en) * | 2003-10-08 | 2012-01-17 | Meiji Seika Pharma Co Ltd | Noncrystalline antibacterial composition containing cefditoren pivoxil |
CA2546115C (en) | 2003-11-14 | 2013-01-08 | Ajinomoto Co., Inc. | Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives |
JP2005162696A (en) * | 2003-12-04 | 2005-06-23 | Nichiko Pharmaceutical Co Ltd | Cefditoren pivoxil pharmaceutical preparation excellent in dissolution property |
NZ587551A (en) | 2004-06-24 | 2012-01-12 | Vertex Pharma | 5-Amino-phenol derivatives such as 5-amino-2,4-di-tert-butyl-phenol |
JP4572296B2 (en) * | 2004-07-21 | 2010-11-04 | トーアエイヨー株式会社 | Pimobendan oral dosage formulation |
JP4572293B2 (en) * | 2004-07-21 | 2010-11-04 | トーアエイヨー株式会社 | Pimobendan oral dosage formulation |
KR101233235B1 (en) * | 2005-08-26 | 2013-02-15 | 에스케이케미칼주식회사 | Pharmaceutical composition of pranlukast solid-dispersion with improved early dissolution rate and the method of preparing the composition |
SI3219705T1 (en) * | 2005-12-28 | 2020-08-31 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of the amorphous form of n-(2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide |
JP4572300B2 (en) * | 2006-01-19 | 2010-11-04 | トーアエイヨー株式会社 | Pimobendan oral dosage formulation |
WO2008114859A1 (en) * | 2007-03-22 | 2008-09-25 | Astellas Pharma Inc. | Pharmaceutical composition containing pyrazole derivative |
KR20100016093A (en) * | 2007-03-30 | 2010-02-12 | 아지노모토 가부시키가이샤 | Medicinal solid-dispersion preparation |
WO2009123169A1 (en) | 2008-04-02 | 2009-10-08 | アステラス製薬株式会社 | Amide derivative-containing pharmaceutical composition |
RU2543714C2 (en) | 2009-03-20 | 2015-03-10 | Вертекс Фармасьютикалз Инкорпорейтед | Method of obtaining modulators of cystic fibrousis transmembrane conductance regulator |
CN103052382B (en) | 2010-07-14 | 2014-10-22 | 千寿制药株式会社 | Solid dispersion of alfa-ketoamide derivatives |
BR112014021090B1 (en) | 2012-02-27 | 2023-01-24 | Vertex Pharmaceuticals Incorporated | PHARMACEUTICAL COMPOSITION AND USE OF N-[2,4-BIS(1,1-DIMETHYLethyl)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE3-CARBOXAMIDE IN THE PREPARATION OF THE SAME |
JP6336246B2 (en) * | 2013-03-13 | 2018-06-06 | 大同化成工業株式会社 | Nanoparticulate preparation and production method thereof |
RU2749213C2 (en) | 2014-10-07 | 2021-06-07 | Вертекс Фармасьютикалз Инкорпорейтед | Co-crystals of transmembrane conduction regulator modulators in cystic fibrosis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2727009B2 (en) * | 1989-03-10 | 1998-03-11 | ダイト株式会社 | Sustained preparation |
-
1995
- 1995-12-20 WO PCT/JP1995/002611 patent/WO1996019239A1/en active Application Filing
- 1995-12-20 AU AU43141/96A patent/AU4314196A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011105070A1 (en) | 2010-02-25 | 2011-09-01 | パナソニック株式会社 | Demand and supply control apparatus, demand and supply control method, and program |
Also Published As
Publication number | Publication date |
---|---|
WO1996019239A1 (en) | 1996-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4314196A (en) | Solid composition with improved solubility and absorbability | |
AU4112497A (en) | Glp-2 derivatives | |
IL122447A0 (en) | Pharmaceutical composition with anaestheric effect | |
AU2070795A (en) | 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives | |
AU2952997A (en) | Thiocyano-triazolyl derivatives and their use as microbicides | |
AU4261697A (en) | Compounds and methods | |
AU2896597A (en) | Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides | |
AU3906295A (en) | Pyrrole derivatives | |
AU3308195A (en) | Antihypertriglyceridemic composition | |
AU2972597A (en) | Compositions and uses thereof | |
AU4161797A (en) | Benzoperimidine-carboxylic acids and derivatives thereof | |
AU3200197A (en) | New composition and methods | |
AU2894997A (en) | Mercapto-imidazolyl derivatives and their use as microbicides | |
AU2084895A (en) | DC-89 derivatives | |
AU3533595A (en) | Chlorobenzene derivative and liquid-crystal composition containing the same | |
AU1454895A (en) | Diphenyloxazoline derivatives | |
AU2152497A (en) | Heterocyclic compounds and their preparation and use | |
AU1724697A (en) | Novel aminophenol derivatives and their use | |
AU691690B2 (en) | Acrolein-releasing composition and use thereof | |
AU3868497A (en) | Benzenesulfone compounds and salts thereof | |
AU2813195A (en) | Composition | |
AU1385595A (en) | Aryl-5-methylene-oxazole derivatives | |
AU1619797A (en) | Vinylene compounds and liquid-crystal composition | |
AU3776495A (en) | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas | |
AU2153197A (en) | Cripowellins and synthetic derivatives thereof |